About Given Imaging (NASDAQ:GIVN)
Given Imaging Ltd (Given) develops, manufactures and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. It is engaged in capsule endoscopy, which is an approach to visual examination of the gastrointestinal tract through the use of a miniaturized video camera contained in an ingestible disposable capsule. Its principal product, which incorporates its core technology, is the Given System, a wireless imaging system that uses its disposable video capsules, the PillCam capsules. The PillCam capsules can be easily ingested by patients and move naturally through the gastrointestinal tract while wirelessly transmitting to a portable recorder, enabling the gastroenterologist to view video, images and data on a computer workstation, utilizing its RAPID software. In October 2012, it acquired the assets related to the SmartPill GI Monitoring System from The SmartPill Corporation.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:GIVN
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $1,755.00
- 200 Day Moving Avg: $1,648.00
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 36.12
- P/E Growth: 0
Frequently Asked Questions for Given Imaging (NASDAQ:GIVN)
What is Given Imaging's stock symbol?
Given Imaging trades on the NASDAQ under the ticker symbol "GIVN."
Who are some of Given Imaging's key competitors?
Some companies that are related to Given Imaging include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), VCA (WOOF), NMC Health PLC (NMC), Valeant Pharmaceuticals Intl (VRX), Catalent (CTLT), Health Net (HNT), Patheon NV (PTHN), Mediclinic International PLC (MDC), Puma Biotechnology (PBYI), Alere (ALR), ConvaTec Group PLC (CTEC) and WuXi PharmaTech (Cayman) (WX).
How do I buy Given Imaging stock?
Shares of Given Imaging can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Given Imaging's stock price today?
MarketBeat Community Rating for Given Imaging (NASDAQ GIVN)MarketBeat's community ratings are surveys of what our community members think about Given Imaging and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Given Imaging stock can currently be purchased for approximately $29.98.
Consensus Ratings for Given Imaging (NASDAQ:GIVN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Given Imaging (NASDAQ:GIVN)
Analysts' Ratings History for Given Imaging (NASDAQ:GIVN)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Given Imaging (NASDAQ:GIVN)Earnings History by Quarter for Given Imaging (NASDAQ GIVN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/6/2013||Q213||$0.18||$0.22||$48.23 million||$49.50 million||View||N/A|
|5/8/2013||Q113||$0.13||$0.06||$44.63 million||$40.60 million||View||N/A|
|2/12/2013||Q412||$0.30||$0.25||$52.93 million||$48.70 million||View||N/A|
|11/6/2012||Q312||$0.22||$0.25||$47.36 million||$45.40 million||View||N/A|
Earnings Estimates for Given Imaging (NASDAQ:GIVN)
Current Year EPS Consensus Estimate: $0.68 EPS
Next Year EPS Consensus Estimate: $0.83 EPS
Dividend History for Given Imaging (NASDAQ:GIVN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Given Imaging (NASDAQ:GIVN)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Given Imaging (NASDAQ:GIVN)
Latest Headlines for Given Imaging (NASDAQ:GIVN)
No headlines for this company have been tracked by MarketBeat.com
Given Imaging (GIVN) Chart for Wednesday, October, 18, 2017